Coya Therapeutics
Coya Therapeutics is a T Reg platform company addressing neurodegenerative, autoimmune, and metabolic diseases
About Coya Therapeutics
Coya Therapeutics is a clinical-stage biotechnology company developing multiple first-in-class and best-in-class approaches that enhance regulatory T cells (Tregs) function in vivo, including allogeneic Treg-derived exosome therapeutics and novel biologics.
Company Facts
- Headquarters
- Houston
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00001_00010
- Funding Stage
- ipo
- Total Funding
- $95,900,000
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2026-01-30
- Website
- coyatherapeutics.com
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Links
Canonical: https://fsome.com/organization/coya-therapeutics-102406 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.